ArticleBlood2010

Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemias.

Pankaj Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.